feed,title,long_url,short_url
MarketWatch,Reviva's stock jumps after experimental schizophrenia drug meets endpoint in Phase 2 clinical trial,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/vRo6IF7HUPI/story.aspx,https://on.mktw.net/3vonFNw
